RUNX1-deficiency drives immune-active ER+ mammary tumorigenesis through activation of interferon signaling
Sen Han, Dongxi Xiang, Xueqing Chen…·Zhe Li
This study shows that RUNX1 loss in ER+ breast cancer promotes immune-active tumor formation through interferon signaling activation.